Most medical device companies begin with an engineer's idea and then search for a clinical problem to fit it. RC Medical takes the opposite approach, according to David Ferrera, CEO of the Lake Forest, California-based medical device venture studio. "We go to the interventional suite first," Ferrera says. "The physicians there see the gaps every week. Our job is to listen, then build the company around what they're actually describing."
RC Medical funds, designs, develops, and commercializes products for the interventional radiology market. Rather than taking on contract work for outside clients, the studio partners directly with physician-entrepreneurs to identify new technology and new indications for devices, then forms a standalone company to carry each idea forward. This approach matters because it places the clinical need at the center of device development, potentially leading to products that better address real-world procedural challenges.
A physician who brings an idea to RC Medical is not handing it off and waiting for a report. Ferrera describes the relationship as a partnership that runs from the first sketch through commercialization. "A physician knows the problem better than anyone," he says. "What we bring is the engineering, the regulatory path, and the discipline to turn that problem into something that can actually reach patients. Neither side can do it alone." That division of labor is the core of the studio model: the physician stays close to the clinical need, while RC Medical manages product development, funding, and the business structure needed to commercialize it.
When an idea clears the early bar, RC Medical does not fold it into an existing product line. It forms a new company around it. "Each idea gets its own company, its own team, its own focus," Ferrera says. "A big portfolio company can lose a good idea in the shuffle. A newco can't afford to." That approach has produced three separate companies out of the studio: Single Pass, Infinity Neuro, and Sonorous NV. Each one grew out of a specific problem a physician described in the interventional suite, and each operates as its own business rather than a product line inside RC Medical.
Ferrera has spent close to three decades building devices for interventional neuroradiology and related fields, including his time as a co-founder of Blockade Medical and as Chief Technology Officer of Balt Global. He says the lesson that carries over to RC Medical is simple: the physicians in these procedures see problems that never make it into a traditional product roadmap. "A catheter that works in a textbook case can still fail in the specific anatomy a physician sees three times a week," he says. "That detail doesn't show up unless you're building with the physician, not for them." The studio model is built to catch that detail early, before a device design is locked in and hard to change.
Ferrera says the studio is not the right fit for every idea that comes through the door, and he does not present it that way to the physicians who bring one in. "Some ideas are better as a feature of an existing product, not a new company," he says. "Part of the first conversation is being honest about which one this is." For the ideas that do become a newco, Ferrera says the physician's involvement does not end once the company is formed. Many stay close to the product as it moves through development and toward the market, which keeps the clinical need in view at every stage rather than only at the start.
The venture studio model could have significant implications for the interventional radiology industry. By forming dedicated companies around physician-identified problems, RC Medical aims to bring devices to market that are more precisely tailored to clinical realities. For physicians, this offers a pathway to turn their insights into tangible solutions. For patients, it could mean access to devices designed with a deeper understanding of the anatomical and procedural challenges they face. As RC Medical continues to build new companies, its model may serve as a blueprint for how medical device innovation can be driven by the clinicians who use the tools every day.
